BioCryst (BCRX) has a consensus price target implying ~118% upside, though the article notes this metric is not very reliable. It argues the more relevant near-term signal is an upward trend in earnings estimate revisions, which could support additional stock upside.
BioCryst (BCRX) has a consensus price target implying ~118% upside, though the article notes this metric is not very reliable. It argues the more relevant near-term signal is an upward trend in earnings estimate revisions, which could support additional stock upside.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
